BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Protein Sciences Corporation 

1000 Research Parkway

Meriden  Connecticut  06450  U.S.A.
Phone: 203-686-0800 Fax: 203-686-0268


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season 9/29/2014 10:13:35 AM
Protein Sciences Corporation And Diamyd Medical AB Deepen Commitment To Develop New Treatment For Diabetes 9/17/2014 7:43:53 AM
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Will Be Available At Over 230 Passport Health Locations Nationwide 8/19/2014 8:12:53 AM
Protein Sciences Corporation And Liomont Announce Licensing Of Proprietary Influenza Vaccines For The Mexico Market 8/12/2014 9:32:40 AM
Protein Sciences Corporation And Partners Launch Health-At-Work To Bring Flublok® And Other Vaccines To The Workplace 7/17/2014 9:56:31 AM
Protein Sciences Corporation Receives Approval From FDA For 2014/15 Formulation Of Flublok® Influenza Vaccine 7/8/2014 10:46:04 AM
U.S. Biomedical Advanced Research And Development Authority (BARDA) Extends Contract With Protein Sciences Corporation 6/18/2014 10:35:11 AM
Protein Sciences Corporation Partners File For Marketing Approval Of Flublok® Influenza Vaccine In Japan 6/2/2014 8:15:23 AM
Protein Sciences Corporation CEO Awarded Honorary Degree For Achievements In Science And Business 5/21/2014 10:29:15 AM
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Availability Update: Product to be Available to Allow Vaccination by Thanksgiving 10/11/2013 8:41:42 AM
12345